Pharmaceutical Packaging Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

Global Pharmaceutical Packaging Market is expected to reach USD 158.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for pharmaceuticals coupled with increased emphasis on product packaging is expected to drive market growth.

Pharmaceutical packaging market comprises wide array of products. The demand for these products is expected to grow rapidly on account of fortification of medicines and drugs against exterior impacts. However, the packaging materials and products need to bear the brunt of stringent government regulations and growing market for counterfeit pharmaceuticals. Counterfeit pharmaceuticals are expected to pose a major threat to manufacturers.

North America is a dominant region in the market backed by thriving pharmaceutical industry and rapid new product introduction. Asia Pacific is anticipated to grow rapidly on account of rising pharmaceutical manufacturing in China and India. The growing trend of contract packaging in the pharmaceutical industry is expected to further augment market growth in Asia Pacific.

Full Research Report on Global Pharmaceutical Packaging Market Analysis:
http://www.grandviewresearch.com/industry-analysis/pharmaceutical-packaging-market

Further key findings from the report suggest:

• Aluminum foil material segment is projected to grow at a CAGR of 7.2% from 2017 to 2025 owing to rising demand for packaging of special purpose drugs.
• Paper and paperboard is the second largest product segment and is expected to reach USD 40.83 billion by 2025 due to growing demand in secondary packaging products.
• Blister packs in the primary pharmaceutical packaging product category is expected to grow at a CAGR of 9.2% from 2017 to 2025 on account of growing demand in oral drugs.
• The market share of Asia Pacific is expected to reach 33% in 2025 owing to growing demand for pharmaceuticals and presence of large number of plastic manufacturers
• The Middle East & Africa region is expected to grow at a CAGR of 5.6% from 2017 to 2025 backed by growing demand for medicines in Tanzania, Nigeria and South Africa.
• The market is highly dispersed due to the presence of a large number of small and large manufacturers

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Pharmaceutical Packaging Market on the basis of material, product, end-use and region:

Pharmaceutical Packaging Material Outlook (Revenue, USD Billion, 2014 - 2025)

• Plastics & Polymers
• HDPE
• Polyester
• LDPE
• PVC
• Paper & Paperboard
• Glass
• Aluminum Foil
• Others

Pharmaceutical Packaging Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Primary Packaging
• Plastic Bottles
• Caps & Closures
• Parenteral Containers
• Blister Packs
• Prefillable Inhalers
• Pouches
• Medication Tubes
• Others
• Secondary Packaging
• Prescription Containers
• Pharmaceutical Packaging Accessories
• Tertiary Packaging

Pharmaceutical Packaging End-use Outlook (Revenue, USD Billion, 2014 - 2025)

• Pharmaceutical Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy
• Others

Pharmaceutical Packaging Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• France
• Asia Pacific
• China
• India
• Japan
• Central & South Africa
• Brazil
• Middle East & Africa

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pharmaceutical-packaging-market           

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Medical Plastic Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

The Global Medical Plastic Market size is expected to reach USD 33.6 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for sterilized plastics for use in the medical industry is expected to emerge as the major factor driving market growth.

The market exhibits an abundance of raw material supply with a large volume of raw material production across North America, Europe, and Asia Pacific. The industry is characterized by the consumption of premium quality high priced products used in the manufacture of healthcare products such as catheters, surgical instruments, and syringes.

The industry is driven by the global population growth, increasing access to the consumers towards healthcare services, primarily in the developing economies, and growing substitution of the metal parts in surgical components. In addition, development of advanced materials with improved strength and performance is expected to benefit the market growth

The industry is characterized by extensive regulations enforced regarding the performance of the products in medical devices. In addition, the industry is expected to be affected by the rejection of Polyvinyl chloride due to concerns regarding the effects the product usage on human health.

Price volatility triggered by spike and decline in the price levels of crude oil is major factor impacting market growth. In addition, increasing demand for the product in alternate applications is expected to pose a threat to the growth, though the effect is likely to be subdued by the growing product adoption over the forecast period.

Full Research Report on Global Medical Plastic Market Analysis:
http://www.grandviewresearch.com/industry-analysis/medical-plastics-market

Further key findings from the report suggest:

• The demand for the product in medical components such as syringes, surgical device components, gloves, and catheter tubing is likely to drive the segment growth at a CAGR of 6.9% by revenue from 2017 to 2025
• Polypropylene is expected to emerge as the fastest growing plastic for medical packaging, registering a CAGR of 9.2% from 2017 to 2025 driven by superior barrier properties and ease of sterilization
• The industry in Asia Pacific was estimated to account for 24.5% of the global revenue in 2016 driven by the growth in consumer healthcare spending coupled with high levels of medical tourism primarily in China and India
• The companies in the industry are involved in the production premium quality plastic composites used for specialized applications in order to achieve a high degree of product differentiation
• The industry is witnesses a large number of investments in research and development for the production of advanced plastics. The development of premium engineered plastics is expected to drive the market growth

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Medical Plastic Market by product, application, and region:

Application Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• Medical Device Packaging
• Polyvinyl Chloride
• Polypropylene
• PETG
• HDPE
• Polystyrene
• PEEK
• Others
• Medical Components
• Polyvinyl Chloride
• Polypropylene
• Polyethylene
• Polycarbonate
• PEEK
• ABS
• Polystyrene
• Engineering Plastics
• Others
• Orthopedic Implant Packaging
• Polyvinyl Chloride
• ABS
• PETG
• Polycarbonate
• Others
• Orthopedic Soft Goods
• Polypropylene
• Silicone
• ABS
• Polycarbonate
• PEEK
• Engineering Plastics
• Wound Care
• Polypropylene
• Thermoplastic Polyurethanes
• Others
• Cleanroom Supplies
• Polyvinyl Chloride
• Polypropylene
• PETG
• Polycarbonate
• PEEK
• ABS
• Polystyrene
• Engineering Plastics
• Others
• BioPharma Devices
• Polycarbonate
• Silicone
• Engineering plastic
• Others
• Mobility Aids
• ABS
• Polycarbonate
• PEEK
• Engineering plastic
• Sterilization and Infection Prevention
• Polypropylene
• Silicone
• ABS
• Polycarbonate
• PEEK
• Engineering plastic
• Tooth Implants
• Polycarbonate
• PEEK
• Others
• Denture Base Material
• PMMA
• Polycarbonate
• Polyamide
• Others
• Other Implants
• Polypropylene
• Silicone
• Polycarbonate
• PEEK
• Engineering Plastics
• Others
• Polyvinyl Chloride
• Polypropylene
• Polystyrene
• Silicone
• ABS
• Polycarbonate

• PEEK

• Engineering plastic

Region Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• UK
• Italy
• France
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-medical-plastics-market          

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Ammonia Market Size Is Likely To Reach $76.64 Billion By 2025

Global Ammonia Market is anticipated to reach USD 76.64 billion by 2025, according to a new report by Grand View Research, Inc. Fertilizer is the major application of the product as well as an important source of nitrogen in the agricultural industry, which is expected to benefit the market over the forecast period.

Liquid ammonia segment dominated the market in 2016. It is majorly used in fertilizer and industrial & household cleaning applications. Ammonia is a colorless and pungent alkaline gas composed of hydrogen and nitrogen. It is an essential gas, which is used in various biological processes and industrial applications. It causes irritation to the eyes, skin, nose, lungs, and throat. Globally governments have established various safety-related regulations associated with the production, usage, and transportation of the product. The regulations also provide some directives for the equipment and methods used during the production process and handling of ammonia.

Globally, the gap between supply & demand of the product is gradually becoming surplus, hence resulting in continuous price fluctuations. This gap is mainly due to continuous capacity additions, especially in Southeast Asia (China and Indonesia), Middle East, Central & South America, and the U.S. The continuous increase in capacity additions and weakening of the demand owing to lower crop prices, poor economic prospects, fluctuating energy prices, and rising competition are anticipated to be the major challenges for the industry over the forecast period.

Full Research Report on Global Ammonia Market Analysis:
http://www.grandviewresearch.com/industry-analysis/ammonia-market

Further key findings from the report suggest:

• The global ammonia market was valued at USD 48.65 billion in 2016. The industry is anticipated to reach USD 76.64 billion by 2025, ascending at a CAGR of 5.3% from 2017 to 2025.
• Fertilizer application segment dominated with over 40% of the overall share in terms of revenue
• Rising demand for nitrogen fertilizer owing to its advantages for application in the agricultural sector is anticipated to boost the ammonia market over the coming years
• Some of the other major application industries of the product include household & industrial cleaning, food & beverage, metallurgical processes, water and wastewater treatment, rubber, pulp & paper, and leather
• Asia Pacific dominated the industry in 2016 and is projected to be the fastest-growing region over the forecast period
• The industry is highly competitive in nature with the presence of various global players
• Some of the key market players are Yara International; BASF SE; CF Industries Holdings; Inc.; PotashCorp; Huaqiang Chemical Group; Shanxi Jinfeng Coal Chemical; Rashtriya Chemicals & Fertilizers Ltd.; China Petroleum & Chemical Corporation; and China National Petroleum Corporation

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the Global Ammonia Market on the basis of product form, application, and region:

Product Form Outlook (Volume, Kilotons; Revenue, USD Million; 2014 - 2025)

• Liquid
• Gas
• Powder

Application Outlook (Volume, Kilotons; Revenue, USD Million; 2014 - 2025)

• Fertilizers
• Refrigerants
• Pharmaceuticals
• Textile
• Others

Regional Outlook (Volume, Kilotons; Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• Russia
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa
• Saudi Arabia

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-ammonia-market         

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Specialty Medical Chairs Market Qualitative Analysis By Industry Overview, Trends, Market Drivers And Restraints 2014-2025

Global Specialty Medical Chairs Market is expected to reach USD 7.65 billion by 2025, according to a new report by Grand View Research, Inc., Increasing geriatric population is expected to boost the adoption of specialty medical chairs. As per WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, population in Asia Pacific region is aging rapidly. More than 211 million people aged 65 years and above were living in East Asia and Pacific in 2010. The older population is expected to grow by 22% every five years in East Asia. This shows the potential demand for these equipment in the coming years.

As per the European Health Interview Survey (EHIS), 51.6 % of the European populace (18 years and above) was overweight in 2014. Rising prevalence of lifestyle-associated diseases, such as diabetes, obesity, chronic kidney disease, and cardiovascular disease, is increasing patient base for the adoption of these products. Furthermore, growing disabled population as a result of a rise in incidence of paralysis and spinal injuries is anticipated to drive the market to some extent. According to CDC, 53 million people in the U.S. are living with a disability.

Increasing reimbursement policies and supportive regulatory framework in developed nations are pushing the market growth. For instance, Medicare policies in the U.S. offer reimbursement for equipment such as wheel chairs, recliners, and other specialty medical chairs. In addition, key market players are offering customized products to meet the various needs of doctors and patients. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.

Full Research Report on Global Specialty Medical Chairs Market Analysis:
http://www.grandviewresearch.com/industry-analysis/specialty-medical-chairs-market

Further Key Findings From the Study Suggest: 

• Rehabilitation specialty medical chair held the dominant share of 40.94% in the market owing to the increasing geriatric population
• Dialysis chair held the largest share in the examination segment owing to increasing prevalence of chronic kidney diseases and technologically advanced products offered by market leaders in this segment
• Treatment segment is anticipated to grow at a steady rate as these products are required for carrying out various treatment procedures and offer better comfort to patients during surgeries or other procedures
• Rehabilitation segment is also expected to grow steadily owing to the rising geriatric population and increasing demand for bathroom aids
• Asia Pacific region is anticipated to grow at a lucrative CAGR of 7.5% owing to improving healthcare infrastructure, growing geriatric population, and rising disposable income, which is anticipated to drive the growth in Asia Pacific region

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Specialty Medical Chairs Market on the basis of product and region:

Specialty Medical Chairs, Product Outlook (Revenue, USD Million, 2014 - 2025)

• Examination Chairs
• Birthing
• Cardiac
• Blood Drawing
• Dialysis
• Mammography
• Treatment Chairs
• Ophthalmic
• ENT
• Dental
• Others
• Rehabilitation Chairs
• Pediatric
• Bariatric
• Geriatric
• Others

Specialty Medical Chairs, Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• The Middle East and Africa
• South Africa
• Saudi Arabianb

View press release of this research report by Grand View Research:http://www.grandviewresearch.com/press-release/global-specialty-medical-chairs-market        

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Foot & Mouth Disease Vaccine Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2014-2025

Global Foot And Mouth Disease (FMD) Vaccine Market is expected to reach USD 3.0 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for lower time period propels repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been a dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing.Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as change in food preferences owing to changing lifestyle coupled with growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Full Research Report on Global Foot and Mouth Disease (FMD) Vaccine Market Analysis:
http://www.grandviewresearch.com/industry-analysis/foot-mouth-disease-fmd-vaccine-market

Further Key Findings from the Report:

• Conventional vaccines emerged as the largest segment because of increasing approvals of vaccines and higher efficacy
• The cattle segment accounted for the largest share in the animal type segment owing to increase in domestic livestock population and number of outbreaks
• Sheep and Goat segment is expected to grow at the fastest rate over the forecast period owing to rising incidence of FMD infection in sheep population and the need for reducing slaughter of infected animals.
• Asia Pacific dominated the market with the largest share in 2016. Rise in incidence of FMD and increase in demand for livestock products are facilitating dominance of the region during the forecast period.

• Key players including Agrovet Co.; Biogénesis Bago; Empresa Colombiana de Productos Veterinarios S.A. Vecol S.A.; FGBI - Federal Centre for Animal Health ; Indian Immunologicals Limited ; Merial (France); Veterinary Serum and Vaccine Research Institute; FMD Center; and Limor de Colombia are leading the global FMD vaccine market.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Foot And Mouth Disease Vaccine Market based on technique, animal type, and region:

Technique Outlook (Revenue, USD Million, 2014 - 2025)

• Conventional vaccines
• Aluminum hydroxide/Saponin-based vaccines
• Oil-based vaccines
• Emergency vaccines

Animal Type Outlook (Revenue, USD Million, 2014 - 2025)

• Cattle
• Sheep and Goat
• Pigs
• Others (antelope, deer, bison, camelids)

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• India
• China
• Japan
• Malaysia
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa
• Nigeria
• Saudi Arabia

View press release of this research report by Grand View Research:http://www.grandviewresearch.com/press-release/global-foot-mouth-disease-fmd-vaccine-market       

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Liquid Biopsy Industry Outlook By Executive Summary, Market Dynamics, Market Size And Growth Prospects 2013-2030

Global Liquid Biopsies Market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant challenges associated with conventional biopsies such as, high level of invasiveness, incompleteness of cancer information that is acquired, associated post-biopsy serious medical complications, and subsequent cost inclusions. A growing need for more advanced, efficient and accurate method which provides a holistic view of the tumor and metastasis is the prime factor fueling rapid development of liquid biopsies.

The market has gained considerable traction in the past couple of years. A number of clinical research projects related to circulating tumor cells, and cell-free tumor DNA have been initiated in the latter half of the past decade. As a result, there are a number of ongoing clinical trials that are due to be completed between post 2017-18. It is expected that upon successful completion, commercialization of these assays and tests will provide the market a significant boost in potential addressable target revenue and fuel growth through to 2030.

Full Research Report on Global Liquid Biopsy Market Analysis:
http://www.grandviewresearch.com/industry-analysis/liquid-biopsy-market

Further key findings from the report suggest:

• In terms of applications, therapy selection of metastatic cancers is the key area of liquid biopsy usage as these provide significant insights into the unique genetic information encoded in CTCs and ctDNAs. Furthermore, with the addition of more research data reinforcing the usage of liquid biopsies over the coming years, it is expected that their application for molecular monitoring of diseases will also be a lucrative source of revenue through to 2030
• Key biomarkers that any liquid biopsy targets include circulating tumor cells, circulating tumor DNA and exosomes that are macrovesicles containing tumor RNA, or tumor protein freely circulating in the patient’s bloodstream. Assays for ctDNA are expected to account for the largest share of revenue through to 2030 owing to the currently present assays and expected number of products that are to be commercialized over the coming decade.
• Development of parallel multi-gene analysis using next generation sequencing technology is the underlying factor that has enabled oncologists to more efficiently sequence ctDNA and gain insights related to cancer metastasis and the related mechanism. This understanding provides a patient-centric systemic view of cancer and aids in its long term monitoring.
• North America, specifically the U.S. accounts for the largest share of revenue for the development of liquid biopsy market. The region was observed to account for around 50% of the global potential in 2015 owing to the high number clinical development projects underway for the commercialization of CTC and ctDNA assays till 2020. Furthermore, throughout the forecast period, U.S. is expected to dominate revenue generation owing to the dynamic nature & being the region of prime activity, research and development with respect to liquid biopsy and next generation sequencing technology.
• Although, post successful commercialization through to 2030, Asia Pacific is expected to be a lucrative region for development as it is expected to be characterized by the presence of a large patient population base, developing healthcare framework and growth in integration of more advanced healthcare practices.
• The market is in its developing phase and is characterized by the presence of a number of relatively smaller entities involved in innovation and new product development. Companies such as Biocept, Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Qiagen, Personal Genome Diagnostics, Cynvenio, RainDance Technologies, and Trovagene are operating in the space and have a number of commercialized assays in their portfolios for liquid biopsy. 
• Furthermore, as this space has a high lucrative potential, and is considerably influenced by the developments in NGS technology, there are a number of major players that have ongoing investigational & observational clinical trials and are due to be completed by 2017 to 2019. Collectively, over 30 clinical trials are currently registered as active by companies including Illumina, Foundation Medicine, Natera Inc., Roche, Sequenom, LabCorp, Epic Sciences, and Pathway Genomics in the U.S. alone. Anticipated successful commercialization of these products is expected to fuel growth over the forecast period.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Liquid Biopsy Market on the basis of application, sample type, biomarker, technology, and region:

Global Liquid Biopsy Outlook, by Application (Revenue, USD Million, 2013 - 2030)

• Therapy Selection for Metastatic Breast Cancer (MBS)
• Therapy Selection for Other Metastatic Cancer
• Molecular Health Monitoring

Global Liquid Biopsy, by Sample Type (Revenue, USD Million, 2013 - 2030)

• Blood Sample based
• Urine Sample based
• Other Bio Fluids (Tissue fluids and Saliva) based

Global Liquid Biopsy Outlook, by Biomarker, (Revenue, USD Million, 2013 - 2030)

• Circulating Tumor Cells (CTC)
• Circulating Tumor DNA (ctDNA)
• Exosomes

Global Liquid Biopsy Outlook, by Biomarker, (Revenue, USD Million, 2013 - 2030)

• Multi - gene - parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

Global Liquid Biopsy Market, Regional Outlook (Revenue, USD Million, 2013 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• MEA
• South Africa

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/liquid-biopsy-market        

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Cold Chain Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

Global Cold Chain Market is anticipated to reach USD 381.68 billion by 2025, according to a new report by Grand View Research, Inc. The expansion of trade over the years has arisen the necessity of making improvements in the packaging of crops as such, the materials used for packaging play a major role in enhancing the storage life.

The development of cold chain is largely responsible for the reduction of wastage of perishable commodities and is vital for the growth of the food sector. Governments across globe provide key services, such as public infrastructure and legislation, which help in facilitating the refrigerated storage development. Furthermore, service providers train employees to enhance technical expertise in the operation and maintenance of specialized facilities.

Emerging countries such as India, Brazil, China, and Mexico are currently undergoing a rapid transition to a consumer-led economy. The retailers in these regions have ample opportunities to expand and grow, owing to the prevailing large number of middle-class income consumers.

Advancements in the technology have enabled service providers to penetrate the emerging markets with innovative solutions to help solve issues relating to complex transportation.

Investment in warehouse automation has been increasing over the past years to meet the customer requirements. High capital investment, running costs, and scalability of different picking methods are the key factors that restrain the market players to automate the warehouses. Furthermore, the growing application of telematics in logistics and transportation is likely to spur the refrigerated transportation market demand.

The retailers and franchise customer have vertical integration with the cold chain service providers to ensure the safety and quality of the product. The lack of cold chain facilities in less-developed economies made retailers to invest heavily in developing own cold chain logistics systems.

The increasing penetration of connected devices and growing usage of RFID, barcode scanners in the refrigerated warehouse is anticipated to drive the monitoring components segment demand over the projected period. The service providers are focusing on adopting new technologies such as cloud technology to enhance the overall logistics performance.

Full Research Report on Global Cold Chain Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cold-chain-market

Further key findings from the report suggest:

• The storage type segment dominates the market in terms of revenue
• The containerization of perishable products is expected to increase the demand for refrigerated containers over the forecast period
• The rapid detection methods, such as nucleic acid-based, immunological-based, and biosensor-based foodborne detection methods, are gaining traction in the market
• The processed food application is expected to register a high CAGR of 12.1% over the projected period
• The Asia Pacific region is expected to portray a high growth rate over the forecast period
• The rising popularity of quick-service restaurants, technological advancements in food packaging, and modern retail trade are driving the processed food application
• The key market players include Lineage Logistics (U.S.), Nordic Logistics (U.S.), Swire Group (UK   ), and Wabash National Corporation (U.S.)

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/ready-to-eat-processed-and-frozen-foods

Grand View Research has segmented the Global Cold Chain Market based on type, application, and region:

Cold Chain Type Outlook (Revenue, USD Billion; 2014 - 2025)

• Storage
• Warehouse
• Refrigerated container
• Transportation
• Road
• Sea
• Rail
• Air
• Monitoring Components

Cold Chain Application Outlook (Revenue, USD Billion; 2014 - 2025)

• Fruits & vegetables
• Dairy
• Fish, meat & seafood
• Processed food
• Pharmaceuticals

Cold Chain Regional Outlook (Revenue, USD Billion; 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• South America
• Brazil
• The Middle East and Africa (MEA)

View Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/cold-chain-market-size-share        

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com